By Stephen Nakrosis
Repare Therapeutics on Monday said its Chief Financial Officer, Steve Forte, has been named as the company's president and chief executive officer, effective April 11.
He succeeds Lloyd Segal, who has resigned as president, CEO, and from the board to pursue other opportunities, Repare said.
Forte, who will continue to serve as CFO, will also join Repare's board.
Forte joined Repare Therapeutics in 2019 as executive vice president and CFO. Before that, he was CFO for Clementia Pharmaceuticals, during which Clementia was acquired by Ipsen for $1.3 billion, Repare said.
In after-hours trading, shares of the oncology company were up 4.5%, to $1.03. The stock has lost 79% over the last year.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
March 31, 2025 17:06 ET (21:06 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.